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Exploring the Association
Between Female Genital
Mutilation/Cutting and HIV
Female genital mutilation/cutting (FGM/C) threatens the health and wellbeing of girls in a variety of ways. Some experts have suggested that human
immunodeficiency virus (HIV) may be among the practice’s adverse health
outcomes. They theorize that because women with FGM/C risk genital trauma
and bleeding during intercourse, their chances of acquiring HIV from an infected
male partner are increased. While evidence that FGM/C increases susceptibility
to HIV could bolster FGM/C eradication efforts, this connection has received
limited research attention.
The Evidence to End FGM/C programme examined the association between
FGM/C and HIV status by:
The Evidence to End FGM/C
programme consortium
generates evidence to
inform and influence
investments, policies, and
programmes for ending
female genital mutilation/
cutting in different contexts.
Population Council
Lead Institution

• Undertaking a rigorous review of existing research literature.1
• Conducting a limited analysis of Demographic and Health Surveys (DHS)
with data available on both FGM/C and HIV from four sub-Saharan African
countries (Ethiopia, The Gambia, Kenya, and Sierra Leone).2
This research summary highlights the programme’s findings on the current
state of evidence on the association between FGM/C and HIV, including the
quality of the existing research and recommendations for further investigation.
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HIV prevalence is low in countries where FGM/C is common, particularly in
countries that practise the most severe form of FGM/C, Type III (see box, page 2).
HIV prevalence is highest in countries where most females are not cut or where
the common FGM/C forms are the less-severe Types I and II. While these patterns
appear to reflect a negative association between FGM/C and HIV overall, some
experts suggest that FGM/C may increase HIV risk for individual women.
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To assess evidence on individual HIV risk among women who have undergone
FGM/C, the researchers thoroughly searched English-language peer-reviewed
academic research and the grey literature (that is, unpublished studies or those
published by an agency or organisation). The review used criteria established
by the United Kingdom’s Department for International Development (DFID),
described in How to Note: Assessing the Strength of Evidence, to identify
studies that met minimum quality standards.3
The review selected only quantitative studies that included FGM/C as an
independent variable, and HIV status—measured by laboratory test—as an
outcome. All the studies were observational (that is, no interventions were
tested). The selected observational studies were acceptable because the
review’s aim was to investigate an association between FGM/C and HIV, not to
establish a cause-and-effect relationship.

The final review included a small set of studies
(14 total) of low to moderate quality based on
DFID’s criteria and represented several African
countries. The findings were inconsistent:
• Four studies showed no association between
FGM/C and HIV.
• Six studies showed a negative association
(women with FGM/C were less likely to be HIV
positive).
• Two studies showed a positive association
(women with FGM/C were more likely to be HIV
positive).
• Two studies showed an indirect association (an
intervening factor appeared to play a role in the
HIV status of women with FGM/C).
The review assessed the body of research and
outlined the potential pathways for an association
between FGM/C and HIV (see table, page 3).
It concluded that not enough evidence was
available to support any of the hypothesized
pathways. Specifically, it showed that no physical
or biological mechanisms linking FGM/C to HIV
transmission have been analysed systematically
and quantitatively; only a handful of the behavioural
mechanisms have been explored, with partial or
mixed results.

Evidence Based on an Analysis
of National Survey Data
The quantitative analysis focused on countries with
nationally representative DHS data available on
both FGM/C and HIV. The six surveys took place in
four sub-Saharan Africa countries: Ethiopia (2005),
The Gambia (2013), Kenya (2003 and 2008-09),
and Sierra Leone (2008 and 2013).
FGM/C was widespread (greater than 70 percent)
in all countries except Kenya (28.7 percent in 200809 and 33.1 percent in 2003). FGM/C Types I and
II were the main types practised in all countries;
in some regions in Ethiopia, Type III was also
common. HIV prevalence ranged from 1.7 percent
(Ethiopia 2005) to 8.7 percent (Kenya 2003).
The analysis showed no difference in HIV
prevalence by FGM/C status in the samples for
Ethiopia, The Gambia, and Sierra Leone. By
contrast, the analysis of both Kenya samples found
that cut women were less likely to be HIV positive
than uncut women. This negative association
among Kenyan women remained statistically
significant even when controlling for demographic
and behavioural variables associated in other
studies with HIV prevalence, such as marital
status, whether a woman was sexually active,

Box

FGM/C Classifications
Type I. Partial or total removal of the clitoris and/
or the prepuce (clitoridectomy).
Type II. Partial or total removal of the clitoris and
the labia minora, with or without excision of the
labia majora (excision).
Type III. Narrowing of the vaginal orifice with
creation of a covering seal by cutting and
appositioning the labia minora and/or the labia
majora, with or without excision of the clitoris
(infibulation).
Type IV. All other harmful procedures to the
female genitalia for nonmedical purposes, for
example, pricking, piercing, incising, scraping,
and cauterization.
Sources: UNAIDS, UNDP, UNECA, UNESCO, UNFPA, UNHCHR,
UNHCR, UNICEF, UNIFEM, and WHO, Eliminating Female Genital
Mutilation: Interagency Statement (Geneva: WHO, 2008).

parity, lifetime number of sexual partners, and
experiencing a sexually transmitted infection.
These findings—that Kenyan women who have
undergone FGM/C are less likely than uncut
women to have HIV—run counter to the theory
that FGM/C raises the odds of HIV. While
acknowledging that the reasons for this association
are not clear, the analysis pointed to previous
studies in Kenya suggesting that marital, premarital,
and extramarital sex may be reduced among cut
women, thus limiting exposure to HIV. In addition,
regional variation in HIV prevalence may influence
exposure. For example, Kenya’s north eastern
region has the nation’s highest FGM/C rates, but its
lowest HIV prevalence rates.
Several possible reasons could explain the
inconsistent findings between Kenya and the other
three countries studied:
• The studies were based on only one point in
time (cross-sectional).
• Other pathways linking FGM/C and HIV may not
have been examined.
• The low HIV-prevalence in Ethiopia, The
Gambia, and Sierra Leone limits the sample
size, making it difficult to draw meaningful
conclusions.
• The considerable geographical variation in HIV
prevalence and FGM/C status complicates
efforts to assess the relationships.
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What We Know
Overall, the findings were inconclusive, with no
solid evidence supporting an association between
FGM/C and HIV. However, further research is
warranted because FGM/C causes trauma to
women’s genitalia, which can increase susceptibility
to sexually transmitted infections such as HIV.

What We Still Need to
Understand
To determine the nature of any relationship
between FGM/C and HIV requires research with
stronger study designs. Recommendations include:
• Improve Measurement. Most of the studies
relied on respondents to self-report whether

they had been cut, yet self-reporting can be
inconsistent. While conducting clinical exams
during DHS implementation is not feasible, other
studies that use different types of samples or
data sources could be designed to supplement
respondents’ reports with clinic records or
physical examination.
• Use Larger Samples. Where possible, focus on
countries and regions with moderate FGM/C and
HIV prevalence to reach an adequate sample
size to enhance the findings’ strength. Consider
conducting a pooled analysis using data from
multiple countries together, considering diverse
populations, HIV prevalence, and FGM/C types
by making “country” one of the control variables.
• Undertake Multi-Level Modelling. This study
design can measure country-level factors,

Table
Evidence for an association between FGM/C and HIV via potential HIV-transmission pathways among
women is inconclusive

Physical
Factors

Behavioural
Factors

PATHWAY

DESCRIPTION

EXPECTED ROLE IN
HIV TRANSMISSION

RESEARCH-BASED
EVIDENCE

Contaminated Equipment

Related to the tools used to
perform the cutting

Increase risk

No evidence

Accompanying Rituals and
Activities

Scarification and tattoos
as part of coming of age
rituals; tetanus vaccination in
advance of the cutting

Increase risk

No evidence

Vulvovaginal Tears

Childbirth blood loss requiring
transfusions, inflammation,
and cell type changes

Increase risk

No evidence

Penile Wounds and
Bleeding

Reported in areas
where Type III FGM/C
predominates.

Increase risk

Not investigated

Infections

Bacterial vaginosis,
candidiasis, and sexually
transmitted infections

Increase risk

Evidence supporting
only part of pathway

Vaginal Dryness

Due to removal of lubricating
glands

Increase risk

Not investigated

Anal Sex

An alternative to obstructed
vaginal intercourse

Increase risk

Not investigated

Coital Infrequency

Due to pain

Decrease risk

No evidence

Lack of Condom Use

More direct exposure

Increase risk

Not investigated

Extramarital Affairs

More partners

Increase risk

Evidence supporting
only part of pathway

Early Marriage/Older Male
Partner

Older males more likely to
be HIV+

Increase risk

Inconsistent
evidence

Early Sexual Debut

Sexual activity before age 19
or 20

Increase risk

Inconsistent
evidence

Widowhood/Divorce

Vulnerable to sexual abuse,
transactional sex due to
economic need/ widows may
have had an HIV+ partner

Increase risk

Evidence supporting
only part of pathway

Source: Y. Abisola Noah-Pinheiro, “Associations Between Female Genital Mutilation/Cutting And HIV: A Review of the Evidence” (New York: Population
Council, forthcoming), based in part on Khady Diouf and Nawal Nour, “Female Genital Cutting and HIV Transmission: Is There an Association?” American
Journal of Reproductive Immunology 69 (Suppl 1, 2013): 45-50.
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such as the labour market, that may influence
behaviour, preferences, and outcomes. Findings
will be most robust with data from 30 or more
FGM/C-practising countries.
• Consider Differentiating Among Types of
HIV and FGM/C. HIV-2, mainly concentrated in
western Africa, is less prevalent, less virulent,
and progresses to AIDS more slowly than the
more widespread HIV-1. These differences
may influence transmission among women with
FGM/C. Establishing a connection between
HIV and FGM/C (if one exists) may be more
difficult in a region where HIV-2 predominates.
In addition, the severity of the FGM/C cut may
affect the odds of HIV.
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